Reversible renal failure: associated with treatment with a beta-adrenergic receptor blocking drug and non-steroidal anti-inflammatory drugs.
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004077:Digoxin / Q000009:adverse effects; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy; D007213:Indomethacin / Q000009:adverse effects; D008297:Male; D008790:Metoprolol / Q000009:adverse effects; D008875:Middle Aged; D010396:Penicillamine / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents; D004077:Digoxin; D008790:Metoprolol; D010396:Penicillamine; D007213:Indomethacin